다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Talaris Therapeutics Inc (TALS)
Talaris Therapeutics Inc (TALS) 뉴스

TALS

Talaris Therapeutics (TALS)

Talaris Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TALS

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/04/20	05:05	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:TALS	Talaris Therapeutics Inc
2024/04/20	05:04	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:TALS	Talaris Therapeutics Inc
2024/04/20	05:02	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:TALS	Talaris Therapeutics Inc
2024/03/20	06:10	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TALS	Talaris Therapeutics Inc
2024/03/20	06:02	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:TALS	Talaris Therapeutics Inc
2024/03/19	20:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TALS	Talaris Therapeutics Inc
2023/11/21	08:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TALS	Talaris Therapeutics Inc
2023/11/21	08:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TALS	Talaris Therapeutics Inc
2023/11/07	06:30	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/31	05:15	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/28	06:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/28	05:02	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/27	06:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/27	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/27	05:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/21	10:23	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/18	06:47	GlobeNewswire Inc.	Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/11	05:32	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/11	05:30	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/07	09:01	Dow Jones News	Stocks to Watch: Shift Technologies, Talaris Therapeutics, Lockheed Martin	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/07	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/07	06:27	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/07	06:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/07	06:09	GlobeNewswire Inc.	Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio	NASDAQ:TALS	Talaris Therapeutics Inc
2023/10/04	21:30	GlobeNewswire Inc.	New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris Therapeutics	NASDAQ:TALS	Talaris Therapeutics Inc
2023/09/26	21:24	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:TALS	Talaris Therapeutics Inc
2023/09/26	21:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TALS	Talaris Therapeutics Inc
2023/09/15	19:31	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:TALS	Talaris Therapeutics Inc
2023/09/15	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:TALS	Talaris Therapeutics Inc
2023/09/14	05:28	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	NASDAQ:TALS	Talaris Therapeutics Inc

검색 관련기사 보기:NASDAQ:TALS

1 2 3 4 5 6 다음 >>

Gold vs US Dollar

Bank of America

Financial Select Sector

Verizon Communications

JP Morgan Chase

Health Care Select Sector

US Dollar vs Yen

American Express

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관